Regulators may need to apply a risk-based approach to assessing and regulating AI, which could be informed through exchange and collaboration in ICMRA.
This assistance is of great importance for countering the consequences of the pandemic, as well as at a time when the U.S. is tightening the blockade against country.
Carnivak-Cov was developed by the Federal Center for Animal Health. It is the first in the world and currently the only registered vaccine against the coronavirus for animals.
GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.